No proof for augmented arterial oxygen content as only factor influencing exercise capacity after Epo doping

Journal of Applied Physiology

Volumn 105, Issue 6, 2008, Pages 1988-

  Boning D ^a   Maassen, N ^b   Pries, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ARTERIAL OXYGEN TENSION; EXERCISE; HEART RATE; HEMODILUTION; HEMOGLOBIN DETERMINATION; HUMAN; LETTER; LUNG DIFFUSION CAPACITY; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL;

ANAEROBIC THRESHOLD; ARTERIES; BLOOD VISCOSITY; DOPING IN SPORTS; ERYTHROPOIETIN, RECOMBINANT; EXERCISE; HEART; HEMODILUTION; HEMOGLOBINS; HUMANS; OXYGEN;

EID: 57349150603     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.91142.2008     Document Type: Letter

References (4)

1. Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R. Effect of thEPO administration on serum levels of sTfR and cycling performance. Med Sci Sport Exer 32: 1238-1243, 2000.
2. Böning D, Maassen N. [Mechanisms of doping with erythropoietin] (in German). Dtsch Z Sportmed 59: 175-177, 2008.
3. Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA. Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport? J Appl Physiol 105: 581-587, 2008.
4. 2 uptake kinetics during exercise in humans. J Physiol 568: 639-652, 2005.